[go: up one dir, main page]

TW200640884A - Novel 3-aryl-1,2-benzisoxazole derivatives, compositions containing same and use thereof - Google Patents

Novel 3-aryl-1,2-benzisoxazole derivatives, compositions containing same and use thereof

Info

Publication number
TW200640884A
TW200640884A TW095105684A TW95105684A TW200640884A TW 200640884 A TW200640884 A TW 200640884A TW 095105684 A TW095105684 A TW 095105684A TW 95105684 A TW95105684 A TW 95105684A TW 200640884 A TW200640884 A TW 200640884A
Authority
TW
Taiwan
Prior art keywords
novel
nr5r6
nitro
represent
halogen
Prior art date
Application number
TW095105684A
Other languages
English (en)
Inventor
Luc Bertin
Chantal Carrez
Fabienne Thompson
Patrick Mailliet
Jean-Marie Ruxer
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35058405&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=TW200640884(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Publication of TW200640884A publication Critical patent/TW200640884A/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/20—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/423—Oxazoles condensed with carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
TW095105684A 2005-02-22 2006-02-21 Novel 3-aryl-1,2-benzisoxazole derivatives, compositions containing same and use thereof TW200640884A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0501801A FR2882361A1 (fr) 2005-02-22 2005-02-22 Nouveaux derives de 3-aryl-1,2-benzisoxazole, compositions les contenant et leur utilisation

Publications (1)

Publication Number Publication Date
TW200640884A true TW200640884A (en) 2006-12-01

Family

ID=35058405

Family Applications (1)

Application Number Title Priority Date Filing Date
TW095105684A TW200640884A (en) 2005-02-22 2006-02-21 Novel 3-aryl-1,2-benzisoxazole derivatives, compositions containing same and use thereof

Country Status (19)

Country Link
US (1) US20080070960A1 (zh)
EP (1) EP1861381A1 (zh)
JP (1) JP2008531493A (zh)
KR (1) KR20070110102A (zh)
CN (1) CN101146780A (zh)
AR (1) AR053684A1 (zh)
AU (1) AU2006217799A1 (zh)
BR (1) BRPI0606178A2 (zh)
CA (1) CA2597781A1 (zh)
EA (1) EA200701798A1 (zh)
FR (1) FR2882361A1 (zh)
IL (1) IL185166A0 (zh)
MA (1) MA29265B1 (zh)
MX (1) MX2007010278A (zh)
NO (1) NO20074631L (zh)
TW (1) TW200640884A (zh)
UY (1) UY29390A1 (zh)
WO (1) WO2006090052A1 (zh)
ZA (1) ZA200707080B (zh)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2907453B1 (fr) * 2006-10-24 2008-12-26 Sanofi Aventis Sa Nouveaux derives du fluorene,compositions les contenant et utilisation
AR077405A1 (es) 2009-07-10 2011-08-24 Sanofi Aventis Derivados del indol inhibidores de hsp90, composiciones que los contienen y utilizacion de los mismos para el tratamiento del cancer
FR2949467B1 (fr) 2009-09-03 2011-11-25 Sanofi Aventis Nouveaux derives de 5,6,7,8-tetrahydroindolizine inhibiteurs d'hsp90, compositions les contenant et utilisation
EP2934145B1 (en) * 2012-12-19 2017-11-15 Celgene Quanticel Research, Inc. Histone demethylase inhibitors

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6884814B2 (en) * 2001-12-13 2005-04-26 Wyeth Phenyl benzisoxazoles as estrogenic agents
EA009919B1 (ru) * 2003-02-11 2008-04-28 Вернэлис (Кембридж) Лимитед Соединения изоксазола
US7538224B2 (en) * 2003-06-27 2009-05-26 Kyowa Hakko Kogyo Co., Ltd. Hsp90 family protein inhibitors
CA2536089A1 (en) * 2003-08-20 2005-03-03 Eli Lilly And Company Ppar modulators

Also Published As

Publication number Publication date
BRPI0606178A2 (pt) 2009-06-02
FR2882361A1 (fr) 2006-08-25
KR20070110102A (ko) 2007-11-15
WO2006090052A1 (fr) 2006-08-31
AU2006217799A1 (en) 2006-08-31
MX2007010278A (es) 2007-11-07
CA2597781A1 (fr) 2006-08-31
ZA200707080B (en) 2008-11-26
EP1861381A1 (fr) 2007-12-05
IL185166A0 (en) 2007-12-03
JP2008531493A (ja) 2008-08-14
NO20074631L (no) 2007-11-20
CN101146780A (zh) 2008-03-19
MA29265B1 (fr) 2008-02-01
AR053684A1 (es) 2007-05-16
US20080070960A1 (en) 2008-03-20
UY29390A1 (es) 2006-10-02
EA200701798A1 (ru) 2008-02-28

Similar Documents

Publication Publication Date Title
UA98116C2 (ru) Изоксазолины, композиция, их применение, способы получения и промежуточные соединения
ATE433981T1 (de) Heterocyclische verbindungen
TW200615267A (en) New bicyclic antibiotics
PE20061303A1 (es) Composicion farmaceutica que comprende oxaprozina
PE20090601A1 (es) Derivados de piridin-il-oxi-piridinas como inhibidores de alk5
ATE453639T1 (de) Phenylsubstituierte pyrimidinverbindungen zur verwendung als kinasehemmer
TW200833670A (en) Novel compounds 569
GEP20115161B (en) Heterocyclic amide derivatives useful as microbiocides
TW200801003A (en) Novel compounds
SMT201300098B (it) Forme solide di N-(4-(7-azabiciclo[2.2.1]eptan-7-il)-2-(trifluorometil)fenil-4-osso-5-trifluorometil)-1,4-diidrochinolina-3-carbossammide
UY30050A1 (es) Derivados de pirimido-oxazinil-fenilo, sales de los mismos, composiciones, preparaciones y aplicaciones
ATE532781T1 (de) 5-(acylamino)indazol-derivate als kinase- inhibitoren
PE20070136A1 (es) COMPUESTOS DERIVADOS DE N-(PIRIDIN-2-IL)-SULFONAMIDA COMO INHIBIDORES DE LA ENZIMA 11-beta-HIDROXIESTEROIDE DESHIDROGENASA HUMANA TIPO 1
MY183331A (en) Crystal form of phenylamino pyrimidine derivatives
TW200502225A (en) Heterocyclic compounds useful as nurr-1 activators
PH12015501098A1 (en) Antituberculous composition comprising oxazole compounds
SE0303541D0 (sv) New compounds
NO20085317L (no) Imidazoazepinonforbindelser
MX2010007351A (es) Derivados de imidazo[1,2-a]piridina-2-carboxamidas, su preparacion y su aplicacion en terapeutica.
DE602006018255D1 (de) Neue 2-amino-benzimidazolderivate und ihre verwendung als modulatoren calciumaktivierter kaliumkanäle mit geringer leitfähigkeit
TW200716529A (en) New compounds II
MX2007003872A (es) Nuevos derivados bis-azaindolicos, preparacion y su uso farmaceutico de los mismos como inhibidores de cinasas.
ATE399168T1 (de) Imidazopyridin-derivate und ihre verwendung als induzierbare no-synthase inhibitoren
TW200607808A (en) Pyrido-pyrimidine derivatives, preparation thereof and application thereof
TW200640884A (en) Novel 3-aryl-1,2-benzisoxazole derivatives, compositions containing same and use thereof